Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Asthma

Free Subscription Articles published in Allergy Retrieve available abstracts of 169 articles: HTML format

Single Articles

January 2026
1. XU Q, Sun Y, Messerlian C, Dong C, et al
   Association Between Fluoride Exposure and Asthma Among US Children and Adolescents.
   Allergy. 2026 Jan 16. doi: 10.1111/all.70214.
   PubMed    
   
   
   
2. CHOI ED, Voehringer D, Radtke D
   Basophils in Skin-Mediated Sensitization Drive Subsequent Lung Inflammation in Airway-Challenged Mice.
   Allergy. 2026;81:220-231.
   PubMed     Abstract available
   
   
   December 2025
3. MOERMANS C, Sabbe M, Onssels A, Bricmont N, et al
   Dupilumab Effectiveness in Biologic-Naive and Switched Severe Asthma in Real Life.
   Allergy. 2025 Dec 24. doi: 10.1111/all.70205.
   PubMed    
   
   
   
4. POTO R, Chan R, Pelaia C, Canonica GW, et al
   The Role of Biologics in Reducing Mucous Plug Burden in Asthma.
   Allergy. 2025 Dec 23. doi: 10.1111/all.70197.
   PubMed     Abstract available
   
   
   
5. PHAM DD, Kwon HS, Song WJ, Cho YS, et al
   Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma.
   Allergy. 2025 Dec 18. doi: 10.1111/all.70186.
   PubMed    
   
   
   
6. HAAHTELA T, O'Mahony L, Traidl-Hoffmann C, Akdis M, et al
   EAACI Guidelines on the Importance of Green Space in Urban Environments for Allergy and Asthma Prevention.
   Allergy. 2025 Dec 13. doi: 10.1111/all.70182.
   PubMed     Abstract available
   
   
   
7. SHRESTHA PALIKHE N, Wu Y, Howie KJ, Stevens C, et al
   Monocyte Chemotactic Factors in the Airways of Patients With Mild Asthma Before and After an Allergen Challenge.
   Allergy. 2025 Dec 12. doi: 10.1111/all.70192.
   PubMed    
   
   
   
8. ANTAO J, Rodrigues G, Zounemat-Kermani N, Montuschi P, et al
   Proteomic and Transcriptomic Signatures of Poor Asthma Symptom Control in the U-BIOPRED Cohort.
   Allergy. 2025 Dec 8. doi: 10.1111/all.70178.
   PubMed     Abstract available
   
   
   
9. NATARAJAN R, Szczesny B, Kanchan K, Esquinca E, et al
   Mediation of Polygenic Asthma Risk Through Gene Expression.
   Allergy. 2025 Dec 6. doi: 10.1111/all.70101.
   PubMed     Abstract available
   
   
   
10. SOUSA-PINTO B, Bousquet J, Vieira RJ, Schunemann HJ, et al
    Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.
    Allergy. 2025 Dec 1. doi: 10.1111/all.70131.
    PubMed     Abstract available
    
    
    November 2025
11. HONG X, Nadeau KC, Frischmeyer-Guerrerio P, Wang G, et al
    Transplacental Antimicrobial Antibodies and Childhood Asthma: Maternal Nativity as an Upstream Factor.
    Allergy. 2025 Nov 27. doi: 10.1111/all.70167.
    PubMed     Abstract available
    
    
    
12. BOUSQUET J, Sousa-Pinto B, Vieira RJ, Schunemann HJ, et al
    Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.
    Allergy. 2025 Nov 21. doi: 10.1111/all.70100.
    PubMed     Abstract available
    
    
    
13. MOREIRA A, Maesano IA, Walusiak-Skorupa J, Han J, et al
    Healthy Planet, Healthier People: EAACI's Integrated Planetary Health Strategy for Asthma, Allergies and Immune Diseases.
    Allergy. 2025 Nov 21. doi: 10.1111/all.70164.
    PubMed    
    
    
    
14. TESTERA-MONTES A, Zubiaga-Fernandez L, Aranda CJ, Garcia-Esteban I, et al
    Long-Term Effect of Allergen Immunotherapy in Responder Local Allergic Rhinitis Patients: Symptom Control, and Prevention of Asthma and Allergic Sensitizations.
    Allergy. 2025 Nov 19. doi: 10.1111/all.70153.
    PubMed     Abstract available
    
    
    
15. VAN AARLE M, Kienhorst S, Vitale R, Bannier M, et al
    Comparison of Two Methods to Analyse Exhaled Breath for Accurate Asthma Detection in School-Aged Children.
    Allergy. 2025 Nov 14. doi: 10.1111/all.70084.
    PubMed    
    
    
    
16. KUKS PJM, Karp T, Hartman JE, Kraft M, et al
    Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort.
    Allergy. 2025 Nov 10. doi: 10.1111/all.70127.
    PubMed     Abstract available
    
    
    
17. KIM MJ, Lee SH, Kim SJ, Song HE, et al
    Association Between Di-(2-Ethylhexyl) Phthalate and Childhood Asthma Through Plasma Metabolome Alterations.
    Allergy. 2025 Nov 3. doi: 10.1111/all.70143.
    PubMed    
    
    
    
18. ASAMOAH K, Yang F, Adcock IM, Vuckovic D, et al
    Trajectory-Based Clustering to Identify Asthma Subgroups Responsive to the Selective CXCR2 Antagonist, AZD5069.
    Allergy. 2025 Nov 2. doi: 10.1111/all.70140.
    PubMed    
    
    
    
19. PARK SO, Uyangaa E, Kim HJ, Byeon HW, et al
    Myeloid cAMP Reduction Shifts Rhinovirus-Induced Airway Inflammation From Neutrophilic to Eosinophilic by Suppressing M1-Interstitial Macrophages.
    Allergy. 2025;80:3055-3076.
    PubMed     Abstract available
    
    
    October 2025
20. WANIN S, Taam RA, Chami LG, Marguet C, et al
    Characteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry.
    Allergy. 2025 Oct 29. doi: 10.1111/all.70119.
    PubMed    
    
    
    
21. TYNECKA M, Tarasik A, Hanczaruk B, Janucik A, et al
    Dynamic Regulation of Collagens, Proteases, Their Inhibitors, and Cell Death in Experimental Asthma in Mice.
    Allergy. 2025 Oct 28. doi: 10.1111/all.70126.
    PubMed     Abstract available
    
    
    
22. SUZUKAWA M, Ohta K, Tashimo H, Narumoto O, et al
    High Serum TSLP Is Characteristic of Late-Onset, Long-Duration, Eosinophilic Asthma.
    Allergy. 2025 Oct 21. doi: 10.1111/all.70109.
    PubMed     Abstract available
    
    
    
23. LUNDING LP, Weckmann M, Zissler UM, Jakwerth C, et al
    Immune Training of the Interleukin 6 Gene in Airway Epithelial Cells is Central to Asthma Exacerbations.
    Allergy. 2025 Oct 16. doi: 10.1111/all.70070.
    PubMed     Abstract available
    
    
    
24. ABOHALAKA R, Ercan S, Lehtimaki L, Lisik D, et al
    Asthma Remission in Adults: Role of Age at Asthma Onset, Smoking, Obesity, and Allergic Rhinitis.
    Allergy. 2025 Oct 15. doi: 10.1111/all.70106.
    PubMed    
    
    
    
25. MARTINI M, Antonicelli L, Garritani MS, Braschi MC, et al
    Efficacy of Dupilumab in Asthma: Focus on Early, Progressive, and Long-Lasting Effects on Small Airways.
    Allergy. 2025 Oct 13. doi: 10.1111/all.70097.
    PubMed    
    
    
    
26. REDEL AL, Feleszko W, Atanaskovic-Markovic M, Arcolaci A, et al
    Antibiotics for Acute Wheezing and Asthma Exacerbations: An EAACI Position Paper and Systematic Review.
    Allergy. 2025 Oct 13. doi: 10.1111/all.70091.
    PubMed     Abstract available
    
    
    
27. ROBERTS G, Just J, Nolte H, Hels OH, et al
    SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic Asthma: A Randomised Phase III Trial.
    Allergy. 2025 Oct 9. doi: 10.1111/all.70073.
    PubMed     Abstract available
    
    
    
28. DENTON E, Jensen ME, Brew BK, Hew M, et al
    Asthma in Pregnancy.
    Allergy. 2025 Oct 6. doi: 10.1111/all.70087.
    PubMed     Abstract available
    
    
    
29. WOEHLK C, Stranzl T, Contoli M, Freemantle N, et al
    Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Children and Adolescents With Allergic Rhinitis and Asthma.
    Allergy. 2025 Oct 1. doi: 10.1111/all.70085.
    PubMed     Abstract available
    
    
    September 2025
30. PRASAD C, Griffard R, Pei D, Haworth S, et al
    Extracellular Vesicle miRNAs as Biomarkers of Asthma Severity.
    Allergy. 2025 Sep 30. doi: 10.1111/all.70079.
    PubMed    
    
    
    
31. HIRAI K, Uehara S, Shirai T, Akamatsu T, et al
    Tezepelumab Targeting Thymic Stromal Lymphopoietin Enhances Steroid Sensitivity in Patients With Severe Asthma.
    Allergy. 2025 Sep 27. doi: 10.1111/all.70083.
    PubMed    
    
    
    
32. KAYIKCI H, Damadoglu E, Cihanbeylerden M, Tuccar C, et al
    Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria.
    Allergy. 2025 Sep 26. doi: 10.1111/all.70078.
    PubMed    
    
    
    
33. NOLASCO S, Fagone E, Campisi R, Portacci A, et al
    Effect of the Arg16Gly beta(2)-Adrenergic Receptor Polymorphism on Long-Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype-Stratified, Multicenter Study.
    Allergy. 2025 Sep 23. doi: 10.1111/all.70071.
    PubMed     Abstract available
    
    
    
34. RATTU A, Dixey P, Charles D, Brightling C, et al
    Predictors of Response to Biologics for Severe Asthma: A Systematic Review and Meta-Analysis.
    Allergy. 2025 Sep 16. doi: 10.1111/all.70031.
    PubMed     Abstract available
    
    
    
35. DA SILVA SENA CR, Martins Costa Gomes G, Kunstle N, Gorlanova O, et al
    Markers in Infants of Mothers With Asthma and Associations With Respiratory Outcomes.
    Allergy. 2025 Sep 15. doi: 10.1111/all.70044.
    PubMed     Abstract available
    
    
    
36. 
    Correction to "The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and A
    Allergy. 2025 Sep 9. doi: 10.1111/all.70035.
    PubMed    
    
    
    
37. HAN A, Deng S, Wang S, Zheng J, et al
    The Uneven Risks of Childhood Asthma Under Extreme Temperatures and Its Interactions With Environmental Factors.
    Allergy. 2025 Sep 5. doi: 10.1111/all.70023.
    PubMed    
    
    
    
38. CAVALEIRO RUFO J, Paciencia I, Jutel M, Moreira A, et al
    The Impact of War on Asthma, a Systematic Review and Meta-Analysis: An EAACI Task Force Report.
    Allergy. 2025 Sep 4. doi: 10.1111/all.70038.
    PubMed     Abstract available
    
    
    
39. CAIN J, Hurrell B, Akbari O
    The Expanding Role of ILC2s in Allergic Airways Disease.
    Allergy. 2025 Sep 2. doi: 10.1111/all.70030.
    PubMed     Abstract available
    
    
    August 2025
40. HUANG HJ, Breyer-Kohansal R, Niespodziana K, Lim CJM, et al
    Molecular IgE Sensitization Profiling With Micro-Arrayed Allergen Molecules in Adult Patients With Asthma From the LEAD Cohort: A Precision Medicine Approach.
    Allergy. 2025 Aug 30. doi: 10.1111/all.70017.
    PubMed     Abstract available
    
    
    
41. HAMELMANN E, Schaub B, Lau S, Bacharier LB, et al
    An Algorithm for the Diagnosis and Management of Severe Asthma in Children and Adolescents.
    Allergy. 2025 Aug 29. doi: 10.1111/all.70027.
    PubMed     Abstract available
    
    
    
42. YAMADA S, Maruoka S, Toyoshima S, Kurosawa Y, et al
    Novel Humanized Mouse Model for Steroid-Resistant Asthma.
    Allergy. 2025 Aug 23. doi: 10.1111/all.70012.
    PubMed    
    
    
    
43. CARRA S, Zhang H, Kurukulaaratchy RJ, Arshad SH, et al
    Natural History of Airway Hyperresponsiveness and Its Association With Asthma Traits.
    Allergy. 2025 Aug 22. doi: 10.1111/all.70006.
    PubMed     Abstract available
    
    
    
44. SHAHBAZI KHAMAS S, Brinkman P, Neerincx AH, Vijverberg SJH, et al
    Complementary Predictors for Asthma Attack Prediction in Children: Salivary Microbiome, Serum Inflammatory Mediators, and Past Attack History.
    Allergy. 2025 Aug 18. doi: 10.1111/all.70004.
    PubMed     Abstract available
    
    
    
45. MARTIN-GONZALEZ E, Perez-Garcia J, Martin-Almeida M, Witonsky J, et al
    Multi-Ancestry Epigenome-Wide Association Study of Asthma Exacerbations.
    Allergy. 2025 Aug 18. doi: 10.1111/all.70016.
    PubMed    
    
    
    
46. KIM SH, Jang JG, Kang MG, Kim Y, et al
    Preventive Role of COVID-19 Vaccination on Future Severe Exacerbation of Asthma According to Severe COVID-19 Status: A Nationwide Population-Based Cohort Study.
    Allergy. 2025 Aug 14. doi: 10.1111/all.70011.
    PubMed    
    
    
    
47. COENEN I, Jones AC, White AA, Takashima M, et al
    Reduced Type-I Interferon by Plasmacytoid Dendritic Cells and Asthma in School-Aged Children.
    Allergy. 2025 Aug 13. doi: 10.1111/all.70005.
    PubMed     Abstract available
    
    
    
48. SUOJALEHTO H, Jeebhay MF, Sander I, Quirce S, et al
    Occupational Mite Allergy and Asthma: An EAACI Task Force Report.
    Allergy. 2025 Aug 13. doi: 10.1111/all.16666.
    PubMed     Abstract available
    
    
    
49. GRANGER V, Nadif R, Orsi L, Chollet Martin S, et al
    Decrease in Eosinophil-Derived-Neurotoxin With Mepolizumab Is Associated With Asthma Improvement.
    Allergy. 2025 Aug 11. doi: 10.1111/all.70008.
    PubMed    
    
    
    
50. MUMMLER C, Milger K
    "Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma".
    Allergy. 2025 Aug 4. doi: 10.1111/all.16685.
    PubMed    
    
    
    
51. DELAUNAY E, Esnault S, Dendooven A, Stoup T, et al
    Associations Between Blood Eosinophil Surface Proteins and Clinical Traits in Severe Asthma and Chronic Rhinosinusitis With Nasal Polyposis.
    Allergy. 2025 Aug 2. doi: 10.1111/all.70001.
    PubMed    
    
    
    
52. CAMINATI M, Annesi-Maesano I, Feleszko W, Guida G, et al
    Fungal-Driven Airways Dis-Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities and Differences.
    Allergy. 2025 Aug 1. doi: 10.1111/all.16687.
    PubMed     Abstract available
    
    
    July 2025
53. ARASI S, Cafarotti A, Galletta F, Panetta V, et al
    Reply to Correspondence "Omalizumab Reduces Anaphylactic Reactions and Allows Food Introduction in Food-Allergic in Children With Severe Asthma: An Observational Study".
    Allergy. 2025 Jul 30. doi: 10.1111/all.16665.
    PubMed    
    
    
    
54. HELEVA A, Lyly A, Salmi V, Makela M, et al
    Efficacy of ASA Therapy After Desensitization on CRSwNP Patients With Asthma and N-ERD-A Randomized Clinical Trial.
    Allergy. 2025 Jul 29. doi: 10.1111/all.16679.
    PubMed     Abstract available
    
    
    
55. XIE YK, Xu SS, Li YS, Li J, et al
    Ficolin-A Protects Against Allergic Asthma via Suppressing ILC2-Drived Type 2 Inflammation.
    Allergy. 2025 Jul 25. doi: 10.1111/all.16661.
    PubMed     Abstract available
    
    
    
56. LISIK D, Backman H, Basna R, Hedman L, et al
    Late-Onset Asthma Phenotypes by Onset Age: A Cluster Analysis in Swedish Population-Based Cohorts.
    Allergy. 2025 Jul 24. doi: 10.1111/all.16680.
    PubMed    
    
    
    
57. JEEBHAY MF, Suojalehto H, Tarlo SM, Suarthana E, et al
    A Novel Questionnaire and Algorithm for Work-Related Asthma Screening and Surveillance: An EAACI Task Force Report.
    Allergy. 2025 Jul 19. doi: 10.1111/all.16647.
    PubMed     Abstract available
    
    
    
58. UTAMI FA, Nguyen NN, Huang SY, Huang SW, et al
    Sugar Intake and Respiratory Consequences: Deciphering the Link Between Drink Choice and Asthma Risk.
    Allergy. 2025 Jul 19. doi: 10.1111/all.16667.
    PubMed    
    
    
    
59. KIM SH, You SH, Lee JW, Kim E, et al
    COVID-19 Pandemic and Decrease in New-Onset Asthma Incidence: National Data From Korea.
    Allergy. 2025 Jul 17. doi: 10.1111/all.16658.
    PubMed    
    
    
    
60. AGACHE I, Balbin-Ramon GJ, Saenz FKF, Sola-Arnau I, et al
    Impact of Residential Greeness Exposure on the Development of Allergic Diseases and Asthma and on Asthma Control-A Systematic Review for the EAACI Guidelines of Environmental Science for Allergic Diseases and Asthma.
    Allergy. 2025 Jul 9. doi: 10.1111/all.16653.
    PubMed     Abstract available
    
    
    
61. SCHLEICH F, Loukides S, Chaudhuri R, Leuppi JD, et al
    Mepolizumab Effectiveness in Severe Asthma With/Without Chronic Rhinosinusitis With Nasal Polyps: Real-World Pooled Analysis.
    Allergy. 2025 Jul 1. doi: 10.1111/all.16618.
    PubMed     Abstract available
    
    
    June 2025
62. WIRTH L, Weigel W, Stamper CT, Kolmert J, et al
    High-Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma.
    Allergy. 2025 Jun 26. doi: 10.1111/all.16633.
    PubMed     Abstract available
    
    
    
63. CANONICA GW, Porsbjerg C, Price DB, Wechsler ME, et al
    Burden of Oral Corticosteroid Use in Severe Asthma: Challenges and Opportunities.
    Allergy. 2025 Jun 23. doi: 10.1111/all.16569.
    PubMed     Abstract available
    
    
    
64. CONTRERAS N, Delgado-Dolset MI, Villasenor A, Escribese MM, et al
    Reply to Correspondence: 'Challenging the Frontier: Bridging Systemic Biomarkers and Small Airway Dynamics in Severe Asthma Management'.
    Allergy. 2025 Jun 20. doi: 10.1111/all.16614.
    PubMed    
    
    
    
65. ATZERT N, Gore C, Knibb RC, Alviani C, et al
    Improved Transition Management of Adolescents and Young Adults With Allergy and/or Asthma: An EAACI Task Force Report on a Follow-Up European Survey.
    Allergy. 2025 Jun 17. doi: 10.1111/all.16603.
    PubMed     Abstract available
    
    
    
66. DONG C, Lu S, Deng Z, Cai X, et al
    Role for Complement C5 in Eosinophilic Inflammation of Severe Asthma.
    Allergy. 2025 Jun 16. doi: 10.1111/all.16616.
    PubMed     Abstract available
    
    
    
67. SHIBUYA K, Balasubramanyam S, Verma D, Holm KE, et al
    Uncontrolled Asthma, Intimate Partner Violence, and Inflammatory Pathways: Surprising Insights From Cytokine Profiles.
    Allergy. 2025 Jun 12. doi: 10.1111/all.16621.
    PubMed    
    
    
    
68. CUCCO A, Simpson A, Haider S, Murray C, et al
    Patterns of Respiratory Symptoms and Asthma Diagnosis in School-Age Children: Three Birth Cohorts.
    Allergy. 2025 Jun 12. doi: 10.1111/all.16617.
    PubMed     Abstract available
    
    
    
69. AGACHE I, Salazar J, Rodriguez-Tanta Y, Saenz FKF, et al
    The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and Asthma.
    Allergy. 2025 Jun 10. doi: 10.1111/all.16611.
    PubMed     Abstract available
    
    
    
70. FENG X, Xue Y, Bao R, Chen S, et al
    Disruption of the Vagal TRPA1-Pulmonary Neuroendocrine Cell Axis Reduces Asthma Severity.
    Allergy. 2025 Jun 10. doi: 10.1111/all.16599.
    PubMed     Abstract available
    
    
    
71. TSAO CL, Chan SY, Lee MH, Hsieh TYJ, et al
    Adverse Outcomes Associated With Short-Acting Beta-Agonist Overuse in Asthma: A Systematic Review and Meta-Analysis.
    Allergy. 2025 Jun 10. doi: 10.1111/all.16538.
    PubMed     Abstract available
    
    
    
72. HERNANDEZ-PACHECO N, Bjorkander S, Merid SK, Kere M, et al
    Genetically Determined Inflammation-Related Proteins in Asthma and Type-2 Signatures.
    Allergy. 2025 Jun 4. doi: 10.1111/all.16608.
    PubMed     Abstract available
    
    
    
73. FUERTES E, Konstantinoudis G, van der Plaat D, Koczoski A, et al
    Vulnerability to Pollen-Related Asthma Hospital Admissions in the UK Biobank: A Case-Crossover Study.
    Allergy. 2025 Jun 3. doi: 10.1111/all.16612.
    PubMed    
    
    
    May 2025
74. KAZADZIS S, Fountoulakis I, Damialis A, Masoom A, et al
    Aerosol Measurements and Decadal Changes: The Role of Climatic Changes and How It Reflects in Respiratory Allergies and Asthma.
    Allergy. 2025 May 31. doi: 10.1111/all.16602.
    PubMed     Abstract available
    
    
    
75. SANZ-RUBIO D, Vera E, Rodriguez-Sanz J, Cubero J, et al
    Linking Exosomal MicroRNA Signatures in Sputum and Peripheral Blood to Inflammatory Endotypes in Severe Asthma.
    Allergy. 2025 May 20. doi: 10.1111/all.16578.
    PubMed    
    
    
    
76. AGACHE I, Torres M, Eguiluz-Gracia I, Bradatan E, et al
    Economic Impact of Allergic Diseases and Asthma-The HEAD Pan-European Registry.
    Allergy. 2025 May 20. doi: 10.1111/all.16596.
    PubMed     Abstract available
    
    
    
77. GATES J, Haris F, Cefaloni F, Khooshemehri P, et al
    Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma.
    Allergy. 2025 May 14. doi: 10.1111/all.16590.
    PubMed     Abstract available
    
    
    
78. LESKIEN M, Thiering E, Yu Z, Huels A, et al
    Childhood Asthma and Allergy Are Related to Accelerated Epigenetic Aging.
    Allergy. 2025 May 10. doi: 10.1111/all.16583.
    PubMed     Abstract available
    
    
    
79. PRICE OJ, Papadopoulos NG, Amerigo DA, Backer V, et al
    Exercise Recommendations and Practical Considerations for Asthma Management-An EAACI Position Paper.
    Allergy. 2025 May 6. doi: 10.1111/all.16573.
    PubMed     Abstract available
    
    
    
80. TOURLAKOPOULOS K, Mavrovounis G, Kontopoulou L, Polyzois S, et al
    Unmasking Convergent Inflammatory and Oxidative Pathways in Asthma.
    Allergy. 2025 May 6. doi: 10.1111/all.16575.
    PubMed    
    
    
    April 2025
81. AN J, Park J, Do AR, Seo S, et al
    Differential DNA Methylation in Peripheral Blood Mononuclear Cells Reflects Asthma Control Status in Adults.
    Allergy. 2025 Apr 19. doi: 10.1111/all.16566.
    PubMed    
    
    
    
82. CHOI S, Yoo SA, Ji KY, Jung DH, et al
    Asthma Alleviation by Ginsenoside Rb1 via Promotion of Treg Proliferation and Inflammatory T Cell Inhibition.
    Allergy. 2025 Apr 19. doi: 10.1111/all.16551.
    PubMed     Abstract available
    
    
    
83. FRICKER M, Harrington J, Hiles SA, Gibson PG, et al
    Circulating Mast Cell Progenitors Are Depleted by Benralizumab in Severe Asthma.
    Allergy. 2025 Apr 19. doi: 10.1111/all.16553.
    PubMed    
    
    
    
84. KLAIN A, Indolfi C, Grella C, Colosimo S, et al
    Correspondence to "Omalizumab Reduces Anaphylactic Reactions and Allows Food Introduction in Food-Allergic in Children With Severe Asthma: An Observational Study".
    Allergy. 2025 Apr 17. doi: 10.1111/all.16560.
    PubMed    
    
    
    
85. AGACHE I, Adcock IM, Akdis CA, Akdis M, et al
    Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.
    Allergy. 2025 Apr 11. doi: 10.1111/all.16557.
    PubMed    
    
    
    
86. 
    Correction to: D.J. Jackson, M.E. Wechsler, G. Brusselle, R. Buhl. Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents. Allergy 2024;1-10. https://doi.org/10.1111/all.16346.
    Allergy. 2025 Apr 3. doi: 10.1111/all.16541.
    PubMed    
    
    
    
87. HILLSON K, Fontanella S, Almeida H, Pavlou B, et al
    Point-of-Care Blood Eosinophils to Predict Preschool Wheeze Attacks.
    Allergy. 2025;80:1038-1046.
    PubMed     Abstract available
    
    
    
88. MANN-NUTTEL R, Mandal S, Armbruster M, Puttagunta L, et al
    Human Pulmonary Neuroendocrine Cells Respond to House Dust Mite Extract With PAR-1 Dependent Release of CGRP.
    Allergy. 2025;80:976-985.
    PubMed     Abstract available
    
    
    March 2025
89. LIPWORTH BJ, Greig R, Chan R, Kuo CR, et al
    Head-To-Head Comparison of Biologic Efficacy in Asthma: What Have We Learned?
    Allergy. 2025 Mar 29. doi: 10.1111/all.16537.
    PubMed     Abstract available
    
    
    
90. SEMENZATO U, Previtero D, Padrin Y, Baraldo S, et al
    Correspondence to "The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper".
    Allergy. 2025 Mar 11. doi: 10.1111/all.16523.
    PubMed    
    
    
    
91. HUANG K, Liu M, Wang W, Shi H, et al
    Asthma Control and Risk Factors for Poor Asthma Outcomes in Chinese Asthma Patients: Baseline Analysis of a Multi-Centre, Single-Arm Study (CARE4ALL).
    Allergy. 2025 Mar 9. doi: 10.1111/all.16522.
    PubMed    
    
    
    
92. HSIN L, Hew M, Aui PM, Deckert K, et al
    A Single Multiplex CytoBas Assay Incorporating Eight Major Components for Accurate Detection of Allergen Sensitization in Asthma and Allergic Rhinitis.
    Allergy. 2025 Mar 7. doi: 10.1111/all.16513.
    PubMed     Abstract available
    
    
    February 2025
93. AGACHE I, Annesi-Maesano I, Cecchi L, Biagioni B, et al
    EAACI Guidelines on Environmental Science for Allergy and Asthma-Recommendations on the Impact of Indoor Air Pollutants on the Risk of New-Onset Asthma and on Asthma-Related Outcomes.
    Allergy. 2025 Feb 28. doi: 10.1111/all.16502.
    PubMed     Abstract available
    
    
    
94. DOMINGO C, Busse WW, Hanania NA, Ertugrul M, et al
    The Direct and Indirect Role of IgE on Airway Epithelium in Asthma.
    Allergy. 2025 Feb 18. doi: 10.1111/all.16459.
    PubMed     Abstract available
    
    
    
95. KIM MS, Lee HW, Choi MS, Lee HS, et al
    Association Between Prevalence of Anemia and Asthma Severity.
    Allergy. 2025 Feb 18. doi: 10.1111/all.16506.
    PubMed    
    
    
    
96. HSU YT, Wu CC, Wang CC, Sheu CC, et al
    Differential Risks of Exposure to Acrylamide in Adult Asthma Clusters.
    Allergy. 2025 Feb 15. doi: 10.1111/all.16503.
    PubMed    
    
    
    
97. KOTSIOU OS, Kirgou P, Siachpazidou D, Bartziokas K, et al
    Correspondence: "Challenging the Frontier: Bridging Systemic Biomarkers and Small Airway Dynamics in Severe Asthma Management".
    Allergy. 2025 Feb 10. doi: 10.1111/all.16498.
    PubMed    
    
    
    
98. MARTIN-GONZALEZ E, Perez-Garcia J, Herrera-Luis E, Martin-Almeida M, et al
    Epigenome-Wide Association Study of Asthma Exacerbations in Europeans.
    Allergy. 2025 Feb 5. doi: 10.1111/all.16490.
    PubMed     Abstract available
    
    
    January 2025
99. KIM DY, Lee S, Jung JH, Sub Y, et al
    GWAS Identifies CACNA2D3 Associated With Asthma and Atopic Dermatitis Multimorbidity in Children.
    Allergy. 2025 Jan 27. doi: 10.1111/all.16483.
    PubMed    
    
    
    
100. ZHANG JL, Zhao CY, Xu XH, Shi C, et al
     Association Between Long-Term Exposure to Ambient Air Pollution and the Risk of Recurrent Asthma Hospitalizations.
     Allergy. 2025 Jan 24. doi: 10.1111/all.16476.
     PubMed    
     
     
     
101. CHANG FM, Lin YF, Chuang HC, Hsu JW, et al
     Early Puberty and Risk of Asthma: Meta-Analysis and Systematic Review.
     Allergy. 2025 Jan 11. doi: 10.1111/all.16471.
     PubMed    
     
     
     
102. FRIEDRICH A, Schmitz MT, Gossmann Y, Redler S, et al
     Comorbid Bronchial Asthma, Atopic Dermatitis and Hashimoto's Thyroiditis Are Risk Factors for Early-Onset, Severe and Prolonged Alopecia Areata.
     Allergy. 2025 Jan 8. doi: 10.1111/all.16468.
     PubMed    
     
     
     
103. DAUD T, Roberts S, Zounemat Kermani N, Richardson M, et al
     The Role of WNT5a and TGF-beta1 in Airway Remodelling and Severe Asthma.
     Allergy. 2025 Jan 3. doi: 10.1111/all.16445.
     PubMed     Abstract available
     
     
     December 2024
104. DOYEN V, Migueres N, van Kampen V, Suojalehto H, et al
     Exhaled Nitric Oxide and Sputum Eosinophils Are Complementary Tools for Diagnosing Occupational Asthma.
     Allergy. 2024 Dec 27. doi: 10.1111/all.16447.
     PubMed     Abstract available
     
     
     
105. PACHECO DA SILVA E, Weinmann T, Gerlich J, Weinmayr G, et al
     Exposure Profiles for the Long-Term Use of Disinfectants and Cleaning Products and Asthma.
     Allergy. 2024 Dec 26. doi: 10.1111/all.16456.
     PubMed     Abstract available
     
     
     
106. SLOB EMA, Vijverberg SJH, Ruffles T, Noij LCE, et al
     Genotype-Guided Asthma Treatment Reduces Exacerbations in Children: Meta-Analysis of Two RCTs.
     Allergy. 2024 Dec 26. doi: 10.1111/all.16438.
     PubMed     Abstract available
     
     
     
107. ESNAULT S, Bernau K, Floerke HL, Dendooven A, et al
     Oncostatin-M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma.
     Allergy. 2024 Dec 21. doi: 10.1111/all.16453.
     PubMed    
     
     
     
108. LUO H, Wen F
     Global Burden of Asthma and Atopic Dermatitis in 2021: A Systemic Analysis of the Global Burden of Disease Study 2021.
     Allergy. 2024 Dec 20. doi: 10.1111/all.16449.
     PubMed    
     
     
     
109. MICHILS A, Hackx M, Mlynarski L, Haccuria A, et al
     How FEV(1) Improvement Induced by Anti-IL-5 in Severe Type-2 Asthma Is Linked to Mucus Plugs Clearance.
     Allergy. 2024 Dec 19. doi: 10.1111/all.16441.
     PubMed    
     
     
     
110. FREEMAN A, Minnion M, Lee PH, Haitchi HM, et al
     Circulating Nitrite in Severe Asthma: Just Another Biomarker or Novel Treatment Target?
     Allergy. 2024 Dec 19. doi: 10.1111/all.16435.
     PubMed    
     
     
     
111. CONTRERAS N, Escolar-Pena A, Delgado-Dolset MI, Fernandez P, et al
     Multiomic Integration Analysis for Monitoring Severe Asthma Treated With Mepolizumab or Omalizumab.
     Allergy. 2024 Dec 18. doi: 10.1111/all.16434.
     PubMed     Abstract available
     
     
     
112. AGACHE I, Adcock IM, Akdis CA, Akdis M, et al
     The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.
     Allergy. 2024 Dec 16. doi: 10.1111/all.16436.
     PubMed     Abstract available
     
     
     
113. LIAO TC, Tsai PC, Lin MC, Wu CC, et al
     Exploring Occupational Asthmagen-Related Asthma Phenotypes: A Cluster Analysis and Machine Learning Study.
     Allergy. 2024 Dec 16. doi: 10.1111/all.16422.
     PubMed    
     
     
     
114. SOENDERGAARD MB, Hansen S, Hakansson KEJ, von Bulow A, et al
     Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma.
     Allergy. 2024 Dec 14. doi: 10.1111/all.16425.
     PubMed     Abstract available
     
     
     
115. GUO H, Zhao Y, Zhang Z, Xu Y, et al
     The Presence and Pathogenic Roles of M(IL-33 + IL-2) Macrophages in Allergic Airway Inflammation.
     Allergy. 2024 Dec 13. doi: 10.1111/all.16430.
     PubMed     Abstract available
     
     
     
116. BILO MB, Martini M, Antonicelli L, de Michele F, et al
     Real-World Finetuning of Biomarkers in Severe Asthma: Longitudinal Latent Class Analysis From the Italian Registry on Severe Asthma (IRSA).
     Allergy. 2024 Dec 6. doi: 10.1111/all.16409.
     PubMed    
     
     
     
117. STOKHOLM J, Thorsen J, Schoos AM, Rasmussen MA, et al
     Infantile colic is associated with development of later constipation and atopic disorders.
     Allergy. 2024;79:3360-3372.
     PubMed     Abstract available
     
     
     November 2024
118. VARRICCHI G, Poto R, Lommatzsch M, Brusselle G, et al
     Biologics and airway remodeling in asthma: early, late, and potential preventive effects.
     Allergy. 2024 Nov 9. doi: 10.1111/all.16382.
     PubMed     Abstract available
     
     
     
119. CHOI DY, Kim AS, Park SY, Kim JH, et al
     Gut permeability and its correlation with patient's traits and blood inflammatory markers in severe asthma: Real-world assessment from the Korean severe asthma registry-2 (KoSAR-2).
     Allergy. 2024 Nov 8. doi: 10.1111/all.16392.
     PubMed    
     
     
     
120. DRAGUNAS G, Koster CS, de Souza Xavier Costa N, Melgert BN, et al
     Neuroplasticity and neuroimmune interactions in fatal asthma.
     Allergy. 2024 Nov 1. doi: 10.1111/all.16373.
     PubMed     Abstract available
     
     
     October 2024
121. VITTE J, Bouazzi L, Barbe C, Pham BN, et al
     Pesticides as an overlooked exposomic association in allergic asthma exacerbations: A nationwide database study.
     Allergy. 2024 Oct 29. doi: 10.1111/all.16380.
     PubMed    
     
     
     
122. MESSAOUD-NACER Y, Culerier E, Rose S, Maillet I, et al
     STING-dependent induction of neutrophilic asthma exacerbation in response to house dust mite.
     Allergy. 2024 Oct 28. doi: 10.1111/all.16369.
     PubMed     Abstract available
     
     
     
123. ZHANG X, Liu J, Li X, Zheng G, et al
     Blocking the HIF-1alpha/glycolysis axis inhibits allergic airway inflammation by reducing ILC2 metabolism and function.
     Allergy. 2024 Oct 27. doi: 10.1111/all.16361.
     PubMed     Abstract available
     
     
     
124. FELESZKO W, Makrinioti H, Nalej M, Ooka T, et al
     Early-life exposure to residential greenness and risk of asthma in a U.S. bronchiolitis cohort.
     Allergy. 2024 Oct 21. doi: 10.1111/all.16359.
     PubMed     Abstract available
     
     
     
125. BEERWEILER CC, Salvermoser M, Theodorou J, Bock A, et al
     Farm-dust mediated protection of childhood asthma: Mass cytometry reveals novel cellular regulation.
     Allergy. 2024 Oct 14. doi: 10.1111/all.16347.
     PubMed     Abstract available
     
     
     
126. JACKSON DJ, Wechsler ME, Brusselle G, Buhl R, et al
     Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents.
     Allergy. 2024 Oct 12. doi: 10.1111/all.16346.
     PubMed     Abstract available
     
     
     September 2024
127. LIN N, Huang Z, Li J, Dong J, et al
     Effects of high-intensity interval training on exercise capacity and asthma-related outcomes in children: A systematic review.
     Allergy. 2024 Sep 30. doi: 10.1111/all.16336.
     PubMed    
     
     
     
128. VAZQUEZ-MERA S, Martelo-Vidal L, Miguens-Suarez P, Bravo SB, et al
     Exploring CD26(-/lo) subpopulations of lymphocytes in asthma phenotype and severity: A novel CD4(+) T cell subset expressing archetypical granulocyte proteins.
     Allergy. 2024 Sep 25. doi: 10.1111/all.16327.
     PubMed     Abstract available
     
     
     
129. ARASI S, Cafarotti A, Galletta F, Panetta V, et al
     Omalizumab reduces anaphylactic reactions and allows food introduction in food-allergic in children with severe asthma: An observational study.
     Allergy. 2024 Sep 16. doi: 10.1111/all.16314.
     PubMed     Abstract available
     
     
     
130. GIJSEN CEW, Bogers TRP, Muris JWM, van van Horck MWP, et al
     Letter to the editor: Efficacy of eHealth monitoring in pediatric asthma.
     Allergy. 2024 Sep 13. doi: 10.1111/all.16317.
     PubMed    
     
     
     
131. RHEE H, Henderson LM, Bauer RN, Wong K, et al
     Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthma.
     Allergy. 2024 Sep 9. doi: 10.1111/all.16309.
     PubMed     Abstract available
     
     
     
132. MELGAARD ME, Jensen SK, Eliasen A, Pedersen CT, et al
     Asthma development is associated with low mucosal IL-10 during viral infections in early life.
     Allergy. 2024 Sep 2. doi: 10.1111/all.16276.
     PubMed     Abstract available
     
     
     August 2024
133. MASTALERZ L, Trad G, Szatkowski P, Cmiel A, et al
     Aspirin hypersensitivity diagnostic index (AHDI): In vitro test for diagnosing of N-ERD based on urinary 15-oxo-ETE and LTE(4) excretion.
     Allergy. 2024 Aug 23. doi: 10.1111/all.16281.
     PubMed     Abstract available
     
     
     
134. CHANTRAN Y, Choi S, Roda C, Nicaise-Roland P, et al
     Higher levels of basal serum tryptase are associated with sensitization, FeNO, allergic morbidity, and lower control of allergic asthma in teenagers from the PARIS birth cohort.
     Allergy. 2024 Aug 19. doi: 10.1111/all.16284.
     PubMed    
     
     
     
135. JABEEN MF, Sanderson ND, Tine M, Donachie G, et al
     Species-level, metagenomic and proteomic analysis of microbe-immune interactions in severe asthma.
     Allergy. 2024 Aug 11. doi: 10.1111/all.16269.
     PubMed     Abstract available
     
     
     
136. FRICKER M, Harrington J, Hiles SA, Gibson PG, et al
     Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma.
     Allergy. 2024 Aug 8. doi: 10.1111/all.16267.
     PubMed     Abstract available
     
     
     
137. MARROCCO A, Mitchel JA, Parker M, McGill M, et al
     Transcriptomic profiles of well-differentiated airway epithelial cells in response to environmental triggers of asthma exacerbation.
     Allergy. 2024 Aug 7. doi: 10.1111/all.16226.
     PubMed    
     
     
     
138. RUPANI H, Busse WW, Howarth PH, Bardin PG, et al
     Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma.
     Allergy. 2024 Aug 1. doi: 10.1111/all.16242.
     PubMed     Abstract available
     
     
     July 2024
139. XU Q, Jia J, Lin H, Liang D, et al
     Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real-life, multi-center study.
     Allergy. 2024 Jul 26. doi: 10.1111/all.16254.
     PubMed    
     
     
     
140. CHIN-SEE-CHONG TCT, Valk JPMJV, Layhadi JAJ, Shamji MHM, et al
     Clinical efficacy of tezepelumab in pre-selected non-type 2 asthma patients.
     Allergy. 2024 Jul 22. doi: 10.1111/all.16237.
     PubMed    
     
     
     
141. FIETEN KB, Drijver-Messelink MT, Wolters R, Hilvering B, et al
     Alpine altitude climate treatment improves asthma control, irrespective of biologics use.
     Allergy. 2024 Jul 12. doi: 10.1111/all.16233.
     PubMed    
     
     
     
142. PERRET JL, Idrose NS, Walters EH, Bui DS, et al
     Childhood infections, asthma and allergy trajectories, and chronic rhinosinusitis in middle age: A prospective cohort study across six decades.
     Allergy. 2024 Jul 10. doi: 10.1111/all.16184.
     PubMed     Abstract available
     
     
     
143. DUMAS O, Le Moual N
     Correspondence to "The impact of indoor pollution on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma".
     Allergy. 2024 Jul 7. doi: 10.1111/all.16224.
     PubMed    
     
     
     June 2024
144. CHEN DF, Su ZQ, Luo YL, Zhou ZQ, et al
     Establishment of a novel severe asthma canine model: Feasible research platform of respiratory intervention therapies.
     Allergy. 2024 Jun 25. doi: 10.1111/all.16207.
     PubMed    
     
     
     
145. DENTON E, Hew M, Peters MJ, Upham JW, et al
     Real-world biologics response and super-response in the International Severe Asthma Registry cohort.
     Allergy. 2024 Jun 22. doi: 10.1111/all.16178.
     PubMed     Abstract available
     
     
     
146. CANELO-AYBAR C, Nieto-Gutierrez W, Rodriguez-Tanta LY, Cantero-Forti Y, et al
     Reply to correspondence: Correspondence to "the impact of indoor pollution on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma".
     Allergy. 2024 Jun 16. doi: 10.1111/all.16195.
     PubMed    
     
     
     
147. BAL C, Stoshikj S, Milger K, Skowasch D, et al
     German asthma net: Nasal polyposis in patients in the severe asthma registry.
     Allergy. 2024 Jun 12. doi: 10.1111/all.16186.
     PubMed    
     
     
     May 2024
148. MUSIOL S, Harris CP, Gschwendtner S, Burrell A, et al
     The impact of high-salt diet on asthma in humans and mice: Effect on specific T-cell signatures and microbiome.
     Allergy. 2024 May 26. doi: 10.1111/all.16148.
     PubMed     Abstract available
     
     
     
149. AGACHE I, Ricci-Cabello I, Canelo-Aybar C, Annesi-Maesano I, et al
     The impact of exposure to tobacco smoke and e-cigarettes on asthma-related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma.
     Allergy. 2024 May 23. doi: 10.1111/all.16151.
     PubMed     Abstract available
     
     
     
150. YANG Y, Cui L, Yu P, Guo J, et al
     Proteomics and metabolomics of sputum reveal the potential impact of allergic rhinitis on asthma.
     Allergy. 2024 May 11. doi: 10.1111/all.16153.
     PubMed    
     
     
     
151. RANJBAR M, Whetstone CE, Cusack RP, Al-Sajee D, et al
     Comparison of upper and lower airway expression of SARS-COV-2 receptors in allergic asthma.
     Allergy. 2024 May 10. doi: 10.1111/all.16157.
     PubMed    
     
     
     
152. PFAAR O, Sousa-Pinto B, Papadopoulos NG, Larenas-Linnemann DE, et al
     Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper.
     Allergy. 2024 May 3. doi: 10.1111/all.16135.
     PubMed     Abstract available
     
     
     April 2024
153. HALVARD HANSEN ES, Kaiser H, Hansen KT, Bonnelykke K, et al
     Association between Apgar scores within normal range and development of asthma, allergic rhinitis and eczema in childhood: A Danish nationwide register study.
     Allergy. 2024 Apr 27. doi: 10.1111/all.16143.
     PubMed    
     
     
     
154. MICHILS A, Makhoul JP, Blekic N, Haccuria A, et al
     Continuous improvement of FEV(1) in severe eosinophilic asthmatics on anti-interleukin-5 therapy.
     Allergy. 2024 Apr 24. doi: 10.1111/all.16139.
     PubMed    
     
     
     
155. NAIR P, Radford K, Nunomura S, Mukherjee M, et al
     Response of sputum periostin to anti-T2 biologics treatment in severe asthma.
     Allergy. 2024 Apr 23. doi: 10.1111/all.16131.
     PubMed    
     
     
     
156. AGACHE I, Annesi-Maesano I, Cecchi L, Biagioni B, et al
     EAACI guidelines on environmental science for allergy and asthma: The impact of short-term exposure to outdoor air pollutants on asthma-related outcomes and recommendations for mitigation measures.
     Allergy. 2024 Apr 2. doi: 10.1111/all.16103.
     PubMed     Abstract available
     
     
     March 2024
157. JUTEL M, Klimek L, Richter H, Bruggenjurgen B, et al
     House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
     Allergy. 2024 Mar 2. doi: 10.1111/all.16052.
     PubMed     Abstract available
     
     
     
158. OKUNISHI K, Kochi Y, Zhao M, Wang H, et al
     Munc13-4 regulates asthma and obesity in mice by controlling functions of CD11c(+) antigen-presenting cells.
     Allergy. 2024 Mar 1. doi: 10.1111/all.16087.
     PubMed    
     
     
     February 2024
159. CARUSO C, Ciasca G, Baglivo I, Di Santo R, et al
     Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?
     Allergy. 2024 Feb 29. doi: 10.1111/all.16082.
     PubMed     Abstract available
     
     
     
160. NADIF R, Henny J, Tsiavia T, Ribet C, et al
     Blood basophils and asthma among participants from CONSTANCES, the French population-based cohort.
     Allergy. 2024 Feb 29. doi: 10.1111/all.16093.
     PubMed    
     
     
     
161. CHEN X, He YQ
     Correspondence to "intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with cecal microbiota changes".
     Allergy. 2024 Feb 25. doi: 10.1111/all.16075.
     PubMed    
     
     
     
162. MORTZ CG, Parke L, Rasmussen HM, Kjaer HF, et al
     A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy.
     Allergy. 2024 Feb 17. doi: 10.1111/all.16046.
     PubMed     Abstract available
     
     
     January 2024
163. ALHAMDAN F, Potaczek DP, Greulich T, Tost J, et al
     Reply to correspondence "Extracellular vesicle microRNA signatures as novel biomarkers in obese asthmatics".
     Allergy. 2024 Jan 29. doi: 10.1111/all.16042.
     PubMed    
     
     
     
164. ZHANG D, Zhang J, Xu C, Qi Q, et al
     A humanized mouse model to study asthmatic airway remodeling and Muc-5ac secretion via the human IL-33.
     Allergy. 2024 Jan 16. doi: 10.1111/all.16030.
     PubMed    
     
     
     December 2023
165. HAMELMANN E, Hammerby E, Scharling KS, Pedersen M, et al
     Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.
     Allergy. 2023 Dec 26. doi: 10.1111/all.15985.
     PubMed     Abstract available
     
     
     
166. SUNDAR IK, Prasad C, Duraisamy SK
     Extracellular vesicle microRNA signatures as novel biomarkers in obese asthmatics.
     Allergy. 2023 Dec 21. doi: 10.1111/all.15979.
     PubMed    
     
     
     
167. SULLIVAN MO, Curtin M, Flynn R, Cronin C, et al
     Telehealth interventions for transition to self-management in adolescents with allergic conditions: A systematic review.
     Allergy. 2023 Dec 1. doi: 10.1111/all.15963.
     PubMed     Abstract available
     
     
     November 2023
168. TRAN NQV, Le MK, Nakamura Y, Kondo T, et al
     A link between KIT expression, mast cell abundance and activity, and Th2-high endotype in asthmatic airways.
     Allergy. 2023 Nov 20. doi: 10.1111/all.15954.
     PubMed    
     
     
     
169. LINDQVIST M, Leth-Moller KB, Linneberg A, Kull I, et al
     Natural course of pollen-induced allergic rhinitis from childhood to adulthood: A 20-year follow up.
     Allergy. 2023 Nov 2. doi: 10.1111/all.15927.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.